Published by Iain Gilbert on 19th July 2022
(Sharecast News) - Drugmaker AstraZeneca's Enhertu has received European Union approval to be used as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer.
URL: http://www.digitallook.com/dl/news/story/32829213/...